AIM: To determine the laryngeal H+K+-ATPase and pharyngeal pH in patients with laryngopharyngeal reflux (LPR)-symptoms as well as to assess the symptom scores during PPI therapy. METHODS: Endoscopy was performed to exclude neoplasia and to collect biopsies from the posterior cricoid area (immunohistochemistry and PCR analysis). Immunohistochemical staining was performed with monoclonal mouse antibodies against human H+K+-ATPase. Quantitative real-time RT-PCR for each of the H+K+-ATPase subunits was performed. The pH values were assessed in the aerosolized environment of the oropharynx (DxpH Catheter) and compared to a subsequently applied combined pH/MII measurement. RESULTS: Twenty patients with LPR symptoms were included. In only one patient, the laryngeal H+K+-ATPase was verified by immunohistochemical staining. In another patient, real-time RT-PCR for each H+K+-ATPase subunit was positive. Fourteen out of twenty patients had pathological results in DxpH, and 6/20 patients had pathological results in pH/MII. Four patients had pathological results in both functional tests. Nine out of twenty patients responded to PPIs. CONCLUSION: The laryngeal H+K+-ATPase can only be sporadically detected in patients with LPR symptoms and is unlikely to cause the LPR symptoms. Alternative hypotheses for the pathomechanism are needed. The role of pharyngeal pH-metry remains unclear and its use can only be recommended for patients in a research study setting.
AIM: To determine the laryngeal H+K+-ATPase and pharyngeal pH in patients with laryngopharyngeal reflux (LPR)-symptoms as well as to assess the symptom scores during PPI therapy. METHODS: Endoscopy was performed to exclude neoplasia and to collect biopsies from the posterior cricoid area (immunohistochemistry and PCR analysis). Immunohistochemical staining was performed with monoclonal mouse antibodies against human H+K+-ATPase. Quantitative real-time RT-PCR for each of the H+K+-ATPase subunits was performed. The pH values were assessed in the aerosolized environment of the oropharynx (DxpH Catheter) and compared to a subsequently applied combined pH/MII measurement. RESULTS: Twenty patients with LPR symptoms were included. In only one patient, the laryngeal H+K+-ATPase was verified by immunohistochemical staining. In another patient, real-time RT-PCR for each H+K+-ATPase subunit was positive. Fourteen out of twenty patients had pathological results in DxpH, and 6/20 patients had pathological results in pH/MII. Four patients had pathological results in both functional tests. Nine out of twenty patients responded to PPIs. CONCLUSION: The laryngeal H+K+-ATPase can only be sporadically detected in patients with LPR symptoms and is unlikely to cause the LPR symptoms. Alternative hypotheses for the pathomechanism are needed. The role of pharyngeal pH-metry remains unclear and its use can only be recommended for patients in a research study setting.
Authors: Stephanie G Worrell; Steven R DeMeester; Christina L Greene; Daniel S Oh; Jeffrey A Hagen Journal: Surg Endosc Date: 2013-07-09 Impact factor: 4.584
Authors: E Roussa; F Thévenod; I Sabolic; C M Herak-Kramberger; W Nastainczyk; R Bock; I Schulz Journal: J Histochem Cytochem Date: 1998-01 Impact factor: 2.479
Authors: Dieter Saur; Barbara Seidler; Günter Schneider; Hana Algül; Roswitha Beck; Reingard Senekowitsch-Schmidtke; Markus Schwaiger; Roland M Schmid Journal: Gastroenterology Date: 2005-10 Impact factor: 22.682
Authors: Steven Shay; Radu Tutuian; Daniel Sifrim; Marcelo Vela; James Wise; Nagammapudur Balaji; Xin Zhang; Talal Adhami; Joseph Murray; Jeffrey Peters; Donald Castell Journal: Am J Gastroenterol Date: 2004-06 Impact factor: 10.864
Authors: Dolores Thea Müller; Elena Schulte; Benjamin Babic; Laura Knepper; Claudia Fuchs; Wolfgang Schröder; Christiane J Bruns; Jessica M Leers; Hans Friedrich Fuchs Journal: World J Gastrointest Surg Date: 2020-05-27